Valuation : PolyNovo Limited

Market Cap 718M 519M 446M 420M 383M 716M 49B 4.97B 1.92B 25.13B 1.95B 1.9B 80.03B P/E 2027 *
73.8x
P/E 2028 * 35.4x
Enterprise Value 678M 490M 421M 396M 361M 676M 46.25B 4.69B 1.81B 23.72B 1.84B 1.8B 75.55B EV / Sales 2027 *
4.19x
EV / Sales 2028 * 3.56x
Free-Float
88.97%
Yield 2027 *
-
Yield 2028 * -
1 day+0.97%
Current month+3.48%
1 month+18.86%
3 months-1.42%
6 months+10.64%
Current year-15.45%
1 week 0.98
Extreme 0.975
1.07
1 month 0.88
Extreme 0.88
1.17
Current year 0.81
Extreme 0.81
1.3
1 year 0.81
Extreme 0.81
1.66
3 years 0.81
Extreme 0.81
2.78
5 years 0.81
Extreme 0.81
2.78
10 years 0.17
Extreme 0.17
4.08
Manager TitleAgeSince
Chief Executive Officer - 2025-11-30
Director of Finance/CFO - 2018-12-11
Chief Tech/Sci/R&D Officer - 2026-05-31
Director TitleAgeSince
Chairman - 2025-10-26
Director/Board Member 65 2019-10-27
Director/Board Member - 2020-05-12
Date Insider Type Main position Quantity % Market Cap. Importance
3/16/26 Buy

Director

151,000 0.0219%
2/27/26 Buy

Director

100,000 0.0145%
2/27/26 Buy

Chairman

30,000 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%0.00%-31.80%-21.51% 513M
-0.42%-3.68%-18.51%+6.67% 187B
+1.15%+3.22%+1.37%+16.68% 120B
-1.86%+2.77%+13.15%+89.47% 63.15B
+0.02%-1.07%+17.69%+45.19% 51.75B
-1.54%-2.52%-3.98%-30.72% 50.32B
-2.02%-3.22%+9.18%-17.76% 33.17B
0.00%+3.71% - - 32.1B
-0.81%+0.74%+35.59%-16.03% 23.93B
-2.41%-6.52%-10.28%+8.53% 22.99B
Average -0.69%-0.52%+1.38%+8.95% 58.58B
Weighted average by Cap. -0.47%-0.64%-1.55%+16.10%

Financials

2027 *2028 *
Net sales 162M 117M 100M 94.5M 86.16M 161M 11.03B 1.12B 433M 5.66B 439M 429M 18.02B 186M 134M 115M 108M 98.85M 185M 12.66B 1.28B 497M 6.49B 503M 492M 20.67B
Net income 9.77M 7.06M 6.07M 5.71M 5.21M 9.75M 667M 67.65M 26.15M 342M 26.49M 25.91M 1.09B 20.34M 14.68M 12.63M 11.88M 10.83M 20.28M 1.39B 141M 54.41M 711M 55.13M 53.92M 2.27B
Net Debt -40.27M -29.07M -25M -23.52M -21.45M -40.15M -2.75B -279M -108M -1.41B -109M -107M -4.49B -57.04M -41.18M -35.42M -33.32M -30.38M -56.88M -3.89B -395M -153M -2B -155M -151M -6.35B
Logo PolyNovo Limited
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.
Employees
301
Date Price Change Volume
26-09-07 A$1.040 +0.97% 3,344,262
26-09-04 A$1.030 +0.98% 1,206,616
26-09-03 A$1.020 +2.00% 1,643,444
26-09-02 A$1.000 -0.50% 1,538,028
26-09-01 A$1.005 0.00% 1,182,114
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1.040AUD
Average target price
1.247AUD
Spread / Average Target
+19.94%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!